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Personalized NanoMedicine: Towards new Theranostic 
Approach
Madhavan Nair*
Center of Personalized NanoMedicine, Institute of Neuroimmune Pharmacology, Department of 
Immunology, Herbert Wertheim College of Medicine, Florida International University, Miami, USA
Since decades, researchers are seeking novel therapeutic strategies to cure and monitor 
diseases for personalized health care needs. Numerous successful efforts are being made to 
design and develop personalized NanoMedicine approach to cure diseases at target site with 
minimum or no adverse effects. The designing of novel nanomaterials, maximum binding 
with therapeutic agent, controlled navigation, on demand or sustained release of drug, good 
biocompatibility, and maximum therapeutic potentials are crucial for effective theranostic 
approaches. Numerous studies have been conducted to formulate NanoMedicine and testing 
its efficacy using various in-vitro models. Unfortunately, such therapeutic nanoformulations 
are not well-tested yet using pre-clinical or human models.
Research group headed by Dr. Nair, at Center of Personalized NanoMedicine, Department 
of Immunology, Herbert Wertheim College of Medicine, Florida International University is 
actively engaged in exploring personalized NanoMedicine approach for target specific drug 
targeting to prevent neuroAIDS in drug using populations (Figure 1) [1-5]. Further the 
research group is also exploring sensing technologies to understand the effect of various 
drugs of abuse and psychological stress in HIV infected patients [6-7].
State-of-the-art, nano-engineered magnetic (Fe3O4) nanocarriers to deliver therapeutic cargo 
across blood brain barrier (BBB) to cure neuro-AIDS in drug addicts have been 
demonstrated [1-5]. To achieve on-demand site specific controlled release of drug, Prof. 
Nair also explored a second generation of magnetic nanoparticles called magneto-electro 
nanoparticles (MENPs) to cure Neuro-AIDS and cancer [1-2]. Presently, efforts are 
continuously being made at Dr. Nair’s laboratory to explore potentials of these 
NanoMedicine formulations to eradicate latent HIV in HIVE-SCID and drug addicted 
animal models. In summary, these studies lead to believe that there is a considerable scope 
to explore and develop novel nano-drug-carriers which are capable to deliver and to release 
desired therapeutics agent in sustained or controlled fashion across blood brain barrier 
(BBB) or any organ in the periphery without any side-effect.
Journal of Personalized NanoMedicine (JPNM) (http://jpnmjournal.org/aims_scope.php) is 
the official journal of the Society for Personalized NanoMedicine (http://s-pnm.org) and the 
purpose of this editorial is to describe the aims and scopes (http://jpnmjournal.org/
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aims_scope.php) of this journal and also to attract researchers for manuscript submission. 
This journal is an open on-line journal to all theoretical and experimental aspects related to 
Personalized NanoMedicine. JPNM invites original research articles, editorials, 
commentaries, prospective, case reports, technical notes, commercialization notes, reviews, 
mini-reviews, communications, and cutting edge-research synopsis to explore 
NanoMedicines for theranostics at personalized health care needs.
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Figure 1. 
Illustration of an externally AC magnetic field stimulated blood brain barrier based drug 
delivery model.
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